InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -18.60% |
| Q3 2025 | 44622.82% |
| Q2 2025 | 0.20% |
| Q1 2025 | -27.49% |
| Q4 2024 | -31.51% |
| Q3 2024 | -34.93% |
| Q2 2024 | -9.95% |
| Q1 2024 | -26.17% |
| Q4 2023 | -45.52% |
| Q3 2023 | -19.01% |
| Q2 2023 | -4.41% |
| Q1 2023 | -39.87% |
| Q4 2022 | -51.97% |
| Q3 2022 | 6.76% |
| Q2 2022 | -32.05% |
| Q1 2022 | -26.28% |
| Q4 2021 | -18.55% |
| Q3 2021 | 41.27% |
| Q2 2021 | -34.61% |
| Q1 2021 | 8.91% |
| Q4 2020 | 84.85% |
| Q3 2020 | -23.55% |
| Q2 2020 | -13.51% |
| Q1 2020 | -26.51% |
| Q4 2019 | -18.33% |
| Q3 2019 | -18.43% |
| Q2 2019 | -14.98% |
| Q1 2019 | -8.42% |
| Q4 2018 | -11.17% |
| Q3 2018 | -12.36% |
| Q2 2018 | 77.02% |
| Q1 2018 | -12.97% |
| Q4 2017 | 89.46% |
| Q3 2017 | -5.09% |
| Q2 2017 | 76.91% |
| Q1 2017 | 105.37% |
| Q4 2016 | 58.65% |
| Q3 2016 | 15.97% |
| Q2 2016 | 64.48% |
| Q1 2016 | -30.90% |